Olfr993 Inhibitors
Olfr993 is a member of the olfactory receptor family responsible for detecting and transducing odorant signals in the nose. These olfactory receptors are a type of G-protein-coupled receptor (GPCR) characterized by a 7-transmembrane domain structure, similar to many neurotransmitter and hormone receptors. Olfr993 plays a crucial role in the recognition and transmission of odorant signals, initiating a neuronal response that ultimately leads to the perception of different smells. Notably, the olfactory receptor gene family is the largest in the genome, reflecting the diversity of odorants in the environment.
Inhibition of Olfr993 can be achieved through various mechanisms, as demonstrated by the inhibitors listed in the table. These inhibitors target specific signaling pathways and cellular processes involved in olfactory signal transduction. For instance, some chemicals interfere with the cAMP signaling pathway, which is essential for olfactory receptor activation. Others disrupt the MAPK pathway or the PI3K/Akt pathway, leading to downregulation or reduced activation of Olfr993. Additionally, certain inhibitors modulate GPCR desensitization, receptor trafficking, and downstream kinases, contributing to the overall inhibition of Olfr993. In summary, Olfr993 is a key player in the olfactory system, responsible for detecting and transmitting odorant signals. Its inhibition can be achieved through various molecular mechanisms, as demonstrated by a range of chemical inhibitors that target specific pathways and processes within the olfactory signaling cascade. These inhibitors offer valuable tools for further understanding olfactory receptor function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin is known to inhibit G-protein signaling, which is essential for olfactory signal transduction through GPCRs. It can indirectly affect Olfr993 function by disrupting this pathway. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker. It inhibits calcium influx, which is crucial for neurotransmitter release in the olfactory system. Reduced calcium levels can lead to decreased olfactory signal transmission. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Bromo-cGMP is a cGMP analog that can modulate the cGMP signaling pathway, which is involved in olfactory receptor signal transduction. Its impact on Olfr993 function may be indirect but significant. | ||||||
D(−)-2-Amino-5-phosphonovaleric acid (D-AP5) | 79055-68-8 | sc-200434 | 5 mg | $97.00 | 2 | |
APV is an NMDA receptor antagonist that can influence glutamate signaling. Altered glutamate signaling can indirectly impact olfactory receptor sensitivity, as glutamate is involved in synaptic transmission. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective PKC inhibitor. PKC is involved in olfactory receptor desensitization. Inhibition of PKC can lead to prolonged olfactory receptor activity and increased sensitivity to odorants. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
BAPTA is an intracellular calcium chelator. It reduces intracellular calcium levels, which are essential for olfactory neurotransmitter release. Lower calcium levels can lead to impaired olfactory signal transmission. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 is a JAK/STAT pathway inhibitor. While not directly linked to olfactory receptors, inhibiting this pathway can influence cytokine signaling in the olfactory system, potentially affecting olfactory receptor function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine is a phosphodiesterase inhibitor that elevates intracellular cAMP levels. It indirectly influences olfactory receptor sensitivity by enhancing the cAMP signaling pathway. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmidazolium is a calmodulin antagonist. It disrupts calmodulin-mediated intracellular processes, potentially affecting calcium-dependent events crucial for olfactory signal transduction and neurotransmission. | ||||||
KT5823 | 126643-37-6 | sc-3534 sc-3534A sc-3534B | 100 µg 1 mg 5 mg | $182.00 $1228.00 $4895.00 | 21 | |
KT5823 is a selective cGMP-dependent protein kinase inhibitor. It modulates the cGMP signaling pathway, indirectly influencing olfactory receptor function, as cGMP is involved in the regulation of olfactory transduction processes. | ||||||